Botox Maker Sues FDA Over Off-Label Marketing Ban
Allergan Inc., the maker of Botox, has filed a suit alleging that the U.S. Food and Drug Administration's prohibition on marketing medications for unapproved uses violates the First Amendment....To view the full article, register now.
Already a subscriber? Click here to view full article